Vesalio Attains Key FDA Clinical Study Milestone

Share on facebook
Share on google
Share on twitter
Share on linkedin
Vesalio Attains Key FDA Clinical Study Milestone


Vesalio announces it has accomplished a key FDA IDE study milestone to support entry into the US neurovascular market. Enrollment in the VITAL(1) clinical trial, assessing the company’s NeVa VS™ technology in the treatment of symptomatic cerebral vasospasm following aneurysmal subarachnoid…

Source

Leave a Replay

PUTIFEROS 😈 – 47. [Prod. Wxsterr]

#Cubo #Leanwayne #Ditrin REC/MIX: @leanwayne7 MASTER: @ice_cobain Produção instrumental: Wxsterr Voz / Letra: @ytalo.cubo, @leanwayne7 e @elditrin83 Arte: @ytalo.cubo TODOS OS DIREITOS RESERVADOS.

Read More »